No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
RNA Avidity Biosciences
- 38.330
- -1.270-3.21%
Close Jun 18 16:00 ET
- 38.320
- -0.010-0.03%
Post 19:59 ET
4.07BMarket Cap-12949P/E (TTM)
39.890High38.040Low1.90MVolume39.130Open39.600Pre Close73.51MTurnover2.19%Turnover RatioLossP/E (Static)106.14MShares42.00052wk High4.90P/B3.33BFloat Cap4.82552wk Low--Dividend TTM87.00MShs Float42.000Historical High--Div YieldTTM4.67%Amplitude4.825Historical Low38.621Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Estimating The Intrinsic Value Of Avidity Biosciences, Inc. (NASDAQ:RNA)
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
SAN DIEGO, June 17, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide C
Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
These mid-cap stocks were the best performers in the last week. Are they in your portfolio?Avidity Biosciences, Inc. (NASDAQ:RNA) shares jumped 50.15% following the announcement that the Phase 1/2 tri
Avidity Biosciences(RNA.US) Officer Sells US$3.72 Million in Common Stock
$Avidity Biosciences(RNA.US)$ Officer MacLean Michael F sold 104.25K shares of common stock on Jun 12, 2024 at an average price of $35.7153 for a total value of $3.72 million.Source: Announcement What
Avidity Biosciences(RNA.US) Director Sells US$3.81 Million in Common Stock
$Avidity Biosciences(RNA.US)$ Director LEVIN ARTHUR A sold 100K shares of common stock on Jun 12, 13, 2024 at an average price of $38.0741 for a total value of $3.81 million.Source: Announcement What
Avidity Biosciences(RNA.US) Officer Sells US$11.59 Million in Common Stock
$Avidity Biosciences(RNA.US)$ Officer Boyce Sarah sold 300K shares of common stock on Jun 12, 13, 14, 2024 at an average price of $38.6277 for a total value of $11.59 million.Source: Announcement What
Comments
The FOMC left rates the same Wednesday afternoon, pointing to about one cut this year. The market was genuinely higher with record index prices.
As a recap just past 10:20 AM EST, the $S&P 500 Index(.SPX.US$ was climbing past a record by 1.23%, the $Dow Jones Industrial Average(.DJI.US$ climbed 0.57%, and the $Nasdaq Composite Index(.IXIC.US$ climbed 1.43%. The indexes gapped higher Wednesday morning, the dow jumping 500...
As a recap just past 10:20 AM EST, the $S&P 500 Index(.SPX.US$ was climbing past a record by 1.23%, the $Dow Jones Industrial Average(.DJI.US$ climbed 0.57%, and the $Nasdaq Composite Index(.IXIC.US$ climbed 1.43%. The indexes gapped higher Wednesday morning, the dow jumping 500...
22
2
$Avidity Biosciences(RNA.US$ Avidity Bioscience Announces Proposed Public Offering Of $300M Of Common Stock
1
Morning mooers! It is Wednesday, June 12th: FOMC rate decision day! The market was lower overall Tuesday but hit all time highs in the S&P 500 and Nasdaq right before the close on Apple AI gains. Today the market is even higher, with most quities climbing.
My name is Kevin Travers, here are stories from the herd on Wall Street today.
$Oracle (ORCL.US)$ climbed 12%, the highest on the S&P 500, after the firm's earnings came ...
My name is Kevin Travers, here are stories from the herd on Wall Street today.
$Oracle (ORCL.US)$ climbed 12%, the highest on the S&P 500, after the firm's earnings came ...
27
$Avidity Biosciences(RNA.US$
IF YOU LOSS THEN REVERSE NOW ( 5X - 15X - 25X ) & TRADE > $100 PRICE ONLY 😊😊😊🌟🌟🌟😍😍😍👍👍👍
IF YOU LOSS THEN REVERSE NOW ( 5X - 15X - 25X ) & TRADE > $100 PRICE ONLY 😊😊😊🌟🌟🌟😍😍😍👍👍👍
$Avidity Biosciences(RNA.US$ Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Etedesiran (AOC 1001) For Myotonic Dystrophy Type 1
Benzinga· 3 mins ago
Benzinga· 3 mins ago
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
NVDAvsTSLA : Just one small interest rate cut made everyone happy
踏雪无痕²⁰²⁰ : OK, very good